"Consulta Reumatologica"

During the past decade, Centro de Estudios Reumatologicos conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 12 clinical trials were completed, i.e. on average, 171.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Estudios Reumatologicos" #1 sponsor was "Pfizer" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "EMD Serono" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Estudios Reumatologicos" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Estudios Reumatologicos" are "Arthritis, Rheumatoid" (3 trials), "Lupus Erythematosus, Systemic" (3 trials), "Rheumatoid Arthritis" (3 trials), "Systemic Lupus Erythematosus" (2 trials) and "Lupus" (1 trials). Many other conditions were trialed in "Centro de Estudios Reumatologicos" in a lesser frequency.

Most popular intervention types in "Centro de Estudios Reumatologicos" are "Drug" (11 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Atacicept 150 mg" (2 trials), "CP-690,550" (2 trials), "Abatacept" (1 trials) and "Abatacept Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Estudios Reumatologicos" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Estudios Reumatologicos". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Centro de Estudios Reumatologicos, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Estudios Reumatologicos, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".